CPG Dengue Infection PDF Final

Introduction

  • Clinical Practice Guidelines (CPG) on Management of Dengue Infection in Adults, Third Edition, published in 2015 by the Ministry of Health Malaysia and Academy of Medicine Malaysia.

Page 2: Publication Details

  • Published by: Malaysia Health Technology Assessment Section (MaHTAS)

  • Contact and Copyright Info: Allows reproduction with proper acknowledgment.

  • Guidelines based on the best available evidence; adherence does not guarantee best outcomes.

  • Guidelines to be reviewed in 4 years or with significant changes.

Page 3: Table of Contents

  1. Epidemiology

    • Dengue Virus and Serotype Trends in Malaysia

    • Clinical Manifestations and Pathophysiology

    • Diagnostic Challenges

  2. Disease Notification

  3. Investigations

    • Disease Monitoring Tests

    • Diagnostic Tests

  4. Management of Dengue Infection

    • Outpatient Management

    • Patient Triaging

    • Criteria for Hospital Admission

    • Disease Monitoring

    • Fluid Management

    • Management of Complications

    • Intensive Care Management

  5. Dengue Infection in Pregnancy

  6. Discharge Criteria

  7. Prevention of Dengue Transmission in Hospitals

  8. Vaccination

  9. Food and Supplements

  10. Implementing the Guidelines

  11. References

  12. Appendices

Page 4: Detailed Content

  • Appendices include Search Strategy, Clinical Questions, WHO Classification of Dengue Fever and Dengue Hemorrhagic Fever, Sample Collection Methods, and Recommended Tests for Diagnosis.

Page 5: Levels of Evidence

  • Level I: Evidence from randomized controlled trial.

  • Level II: Evidence from controlled trials without randomization or cohort studies.

  • Level III: Opinions based on clinical experience or reports from committees.

  • Emphasis on incorporating GRADE methodology for evidence assessment.

Page 6-9: Guidelines Development

  • Involvement of multidisciplinary teams for literature review and guideline development.

  • Literature search limited to last five years and English publications.

  • Engagement with experts to identify relevant studies.

Page 8: Objectives

  • General Objective: Provide evidence-based guidance for managing adult dengue patients.

  • Specific Objectives:

    • Improve recognition and diagnosis

    • Enhance notification processes

    • Identify severe dengue cases

    • Guide fluid management

    • Raise awareness of complications.

  • Target Population: Adults with dengue fever, especially healthcare professionals.

Page 12-13: Epidemiology

  • Dengue is a major public health issue with rising incidence in Malaysia.

  • Highest incidences among urban populations aged 15+.

  • Case fatality decreased from 0.6% (2000) to 0.2% (2014).

Page 13-14: Dengue Virus and Serotype Trends

  • Caused by four serotypes (DENV-1 to DENV-4).

  • Secondary infections are risk factors for severe dengue.

  • Predominant serotypes can change; monitored closely.

Page 14-18: Clinical Manifestations and Pathophysiology

  • Symptoms range from mild to severe, with critical phases involving plasma leakage.

  • Critical phase is marked by complications such as shock, bleeding, and organ dysfunction.

  • Understanding phases aids management decisions.

Page 18: WHO Classification

  • Clear criteria delineate Dengue Fever (DF), Dengue Hemorrhagic Fever (DHF), and Dengue Shock Syndrome (DSS).

  • Recognition of limitations in earlier classification methods.

Page 19-20: Diagnostic Challenges

  • High suspicion needed as symptoms are non-specific.

  • Notification to health authorities is mandatory for suspected dengue cases.

  • Laboratory confirmation essential for case registration.

Page 20-23: Investigations

  • Laboratory Tests:

    • White cell and platelet counts decrease as dengue progresses.

    • Haematocrit (HCT) indicates plasma leakage.

    • Diagnostic tests include NS1 antigen tests, ELISA, and RT-PCR.

    • Test interpretation should consider clinical context.

Page 24-33: Management of Dengue Infection

  • Outpatient Management:

    • Symptomatic and supportive care recommended.

  • Fluid Management:

    • Important to monitor for warning signs.

    • IV fluids suggested for severe cases.

Page 33-38: Fluid Management for Shock

  • Differentiation between compensated and decompensated shock is critical.

  • Algorithms A, B, and C provide guidelines for handling different shock scenarios.

Page 38-49: Intensive Care Management

  • Specific indications for ICU referral outlined.

  • Management of respiratory, cardiovascular, neurological, and renal complications.

Page 50-53: Dengue Infection in Pregnancy

  • Increased risk of severe dengue outcomes in pregnant women.

  • Close monitoring and early referrals are essential.

Page 53-54: Discharge Criteria

  • Patients should meet specific health improvement criteria before discharge.

Page 54-63: Implementing and Preventing Dengue Transmission

  • Critical to standardize management across healthcare scenarios.

  • Community involvement in prevention is essential.

Page 74-76: Appendices and Home Care

  • Helpful resources and monitoring charts for outpatient care.

  • Home care advice for dengue patients concerning hydration, rest, and monitoring symptoms.

Page 78-80: Acknowledgements and References

  • Note on funding and contributions from various healthcare professionals.